Affiliation:
1. Allegheny General Hospital and
2. Interpace Diagnostics, Pittsburgh, PA.
Abstract
Abstract
Thyroid neoplasms comprise a heterogeneous group of tumors, arising most commonly from follicular cells. While some neoplasms such as the papillary thyroid carcinoma have been widely studied and reported in the literature, our knowledge of the less common entities, including anaplastic thyroid carcinoma and medullary thyroid carcinoma is still deficient. In the current medical era, molecular characteristics of the tumors are being increasingly evaluated for their potential role in establishing diagnosis and to guide management. In this review article, we discuss some of the less common thyroid neoplastic entities, with a special focus on their molecular profiles. In addition, we share our own institutional experience obtained from molecular profiling of anaplastic thyroid carcinoma and medullary thyroid carcinoma.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Pathology and Forensic Medicine
Reference51 articles.
1. Cancer statistics, 2018;CA Cancer J Clin,2018
2. Pathology of endocrine tumors update: World Health Organization new classification 2017—other thyroid tumors;AJSP Rev Rep,2017
3. Anaplastic thyroid carcinoma: an epidemiologic, histologic, immunohistochemical and molecular single-institution study;Hum Pathol,2018
4. PAX8 immunostaining of anaplastic thyroid carcinoma: a reliable means of discerning thyroid origin for undifferentiated tumors of the head and neck;Hum Pathol,2011
5. BRAF V600E inhibition in anaplastic thyroid cancer;N Engl J Med,2013